Grading dermatologic adverse events of cancer treatments: The common terminology criteria for adverse events version 4.0

Alice P. Chen; Ann Setser; Milan J. Anadkat; Jonathan Cotliar; Elise A. Olsen; Benjamin C. Garden; Mario E. Lacouture

doi:10.1016/j.jaad.2012.02.010

Grading dermatologic adverse events of cancer treatments: The common terminology criteria for adverse events version 4.0

Alice P. Chen, Ann Setser, Milan J. Anadkat, Jonathan Cotliar, Elise A. Olsen, Benjamin C. Garden, Mario E. Lacouture

Research output: Contribution to journal › Review article › peer-review

289 Scopus citations

Abstract

Dermatologic adverse events to cancer therapies have become more prevalent and may to lead to dose modifications or discontinuation of life-saving or prolonging treatments. This has resulted in a new collaboration between oncologists and dermatologists, which requires accurate cataloging and grading of side effects. The Common Terminology Criteria for Adverse Events Version 4.0 is a descriptive terminology and grading system that can be used for uniform reporting of adverse events. A proper understanding of this standardized classification system is essential for dermatologists to properly communicate with all physicians caring for patients with cancer.

Original language	English
Pages (from-to)	1025-1039
Number of pages	15
Journal	Journal of the American Academy of Dermatology
Volume	67
Issue number	5
DOIs	https://doi.org/10.1016/j.jaad.2012.02.010
State	Published - 2012

Keywords

Adverse events
Cancer treatment
Common terminology criteria for adverse events
Drug reactions
Grading system
Side effects

Access to Document

10.1016/j.jaad.2012.02.010

Cite this

@article{439fd4ce1ced48d6a162a2286b58b490,

title = "Grading dermatologic adverse events of cancer treatments: The common terminology criteria for adverse events version 4.0",

abstract = "Dermatologic adverse events to cancer therapies have become more prevalent and may to lead to dose modifications or discontinuation of life-saving or prolonging treatments. This has resulted in a new collaboration between oncologists and dermatologists, which requires accurate cataloging and grading of side effects. The Common Terminology Criteria for Adverse Events Version 4.0 is a descriptive terminology and grading system that can be used for uniform reporting of adverse events. A proper understanding of this standardized classification system is essential for dermatologists to properly communicate with all physicians caring for patients with cancer.",

keywords = "Adverse events, Cancer treatment, Common terminology criteria for adverse events, Drug reactions, Grading system, Side effects",

author = "Chen, {Alice P.} and Ann Setser and Anadkat, {Milan J.} and Jonathan Cotliar and Olsen, {Elise A.} and Garden, {Benjamin C.} and Lacouture, {Mario E.}",

note = "Publisher Copyright: {\textcopyright} 2012 by the American Academy of Dermatology, Inc.",

year = "2012",

doi = "10.1016/j.jaad.2012.02.010",

language = "English",

volume = "67",

pages = "1025--1039",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

number = "5",

}

TY - JOUR

T1 - Grading dermatologic adverse events of cancer treatments

T2 - The common terminology criteria for adverse events version 4.0

AU - Chen, Alice P.

AU - Setser, Ann

AU - Anadkat, Milan J.

AU - Cotliar, Jonathan

AU - Olsen, Elise A.

AU - Garden, Benjamin C.

AU - Lacouture, Mario E.

PY - 2012

Y1 - 2012

N2 - Dermatologic adverse events to cancer therapies have become more prevalent and may to lead to dose modifications or discontinuation of life-saving or prolonging treatments. This has resulted in a new collaboration between oncologists and dermatologists, which requires accurate cataloging and grading of side effects. The Common Terminology Criteria for Adverse Events Version 4.0 is a descriptive terminology and grading system that can be used for uniform reporting of adverse events. A proper understanding of this standardized classification system is essential for dermatologists to properly communicate with all physicians caring for patients with cancer.

AB - Dermatologic adverse events to cancer therapies have become more prevalent and may to lead to dose modifications or discontinuation of life-saving or prolonging treatments. This has resulted in a new collaboration between oncologists and dermatologists, which requires accurate cataloging and grading of side effects. The Common Terminology Criteria for Adverse Events Version 4.0 is a descriptive terminology and grading system that can be used for uniform reporting of adverse events. A proper understanding of this standardized classification system is essential for dermatologists to properly communicate with all physicians caring for patients with cancer.

KW - Adverse events

KW - Cancer treatment

KW - Common terminology criteria for adverse events

KW - Drug reactions

KW - Grading system

KW - Side effects

UR - http://www.scopus.com/inward/record.url?scp=84872679025&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2012.02.010

DO - 10.1016/j.jaad.2012.02.010

M3 - Review article

C2 - 22502948

AN - SCOPUS:84872679025

SN - 0190-9622

VL - 67

SP - 1025

EP - 1039

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 5

ER -

Grading dermatologic adverse events of cancer treatments: The common terminology criteria for adverse events version 4.0

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this